Figure 5A compares typical cleaved caspase-3 stained DiFi/HCT116 tumor slices treated with PBS/cetuximab at baseline (no treatment), day 4 (2 treatments), and day 8 (4 treatments). This evidence concerns the gene CASP3 and neoplasm.